| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |